Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Prostatic Intraepithelial Neoplasia 1Precancerous Conditions 1Neoplasms 1

Interventions

Whole-Body Irradiation 4Sulindac 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4fludarabine phosphate 3Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Cetuximab 3Biopsy 3Tacrolimus 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Polymerase Chain Reaction 2Oxycodone 2Mycophenolic Acid 2Melphalan 2Gene Expression Profiling 2Etoposide 2Darbepoetin alfa 2Cyclosporine 2Cyclophosphamide 2Cisplatin 2Busulfan 2Aspirin 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2vandetanib 1soybean oil, phospholipid emulsion 1ruxolitinib 1polyphenon E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Toremifene × Other neoplasm × Clear all
NCT00106691 2023-06-12

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

GTx

Phase 3 Completed
1,589 enrolled 16 charts
GenitourinaryOther neoplasm

Neoplasms, Precancerous Conditions, Prostatic Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡